Gefitinib upregulates death receptor 5 expression to mediate rmhTRAIL-induced apoptosis in Gefitinib-sensitive NSCLC cell line

BACKGROUND: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in tumor cells, but when used alone, it is not effective in the treatment of TRAIL-resistant tumors. Some studies have shown that gefitinib interacts with recombinant mutant human TRAIL (rmhTRAIL) to induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Dong, Ge, Yang, Deng, Haiteng, Chen, Wenming, An, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498723/
https://www.ncbi.nlm.nih.gov/pubmed/26170696
http://dx.doi.org/10.2147/OTT.S73731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498723/
https://www.ncbi.nlm.nih.gov/pubmed/26170696
http://dx.doi.org/10.2147/OTT.S73731

Ejemplares similares